Terms: = Thyroid cancer AND TRRAP, TR-AP, 8295, ENSG00000196367, Q9Y4A5, PAF400, PAF350/400, FLJ10671, STAF40, Tra1 AND Clinical Outcome
2 results:
1. Development and validation of an individualized nomogram for predicting the high-volume (> 5) central lymph node metastasis in papillary thyroid microcarcinoma.
Wei X; Min Y; Feng Y; He D; Zeng X; Huang Y; Fan S; Chen H; Chen J; Xiang K; Luo H; Yin G; Hu D
J Endocrinol Invest; 2022 Mar; 45(3):507-515. PubMed ID: 34491546
[TBL] [Abstract] [Full Text] [Related]
2. Epitope-Specific Antitumor Immunity Suppresses Tumor Spread in Papillary thyroid cancer.
Ehlers M; Kuebart A; Hautzel H; Enczmann J; Reis AC; Haase M; Allelein S; Dringenberg T; Schmid C; Schott M
J Clin Endocrinol Metab; 2017 Jul; 102(7):2154-2161. PubMed ID: 27860539
[TBL] [Abstract] [Full Text] [Related]
